Pfizer Announces It's Splitting Up Its Drug Business

  • Playlist
  • Download
  • Embed
    Embed <iframe src="http://www.npr.org/player/embed/206884486/206884457" width="100%" height="290" frameborder="0" scrolling="no">
  • Transcript

The world's largest drugmaker says it's planning on dividing its business into separate units for brand-name drugs and generics. The company's generics have a far lower profit margin than drugs protected by patents.

(SOUNDBITE OF MUSIC)

DAVID GREENE, HOST:

NPR's business news starts with changes for Pfizer.

The world's largest drug maker is getting ready for a split. Pfizer says it's planning on dividing its business into separate units for brand-name drugs and generics. The company's generics have a far lower profit margin than drugs protected by patents. This morning, Pfizer released its second quarter earnings, which came in just above analyst's expectations. Many analysts have been calling on the company to completely spin off its generic business, but that wouldn't happen for a few years.

Copyright © 2013 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR’s programming is the audio.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.